FTSE 100 Breaks FourWeek Losing Streak as Softer Inflation and Weak Retail Sales Ease Rate Hike Concerns SpaceX Faces A Crucial Launch Test Ahead Of Its IPO Zscaler Shares Drop 24 in Premarket Trading After Cautious Outlook Rising Fuel Costs Fuel Surge in LowSpeed ECycle Adoption Across Urban India Birds Nest on Ford F250 Delays Vehicle Sale Legal Implications for Dealerships Treasury Yield Surge Challenges RiskFree Label Opens Opportunities in Intermediate BBB and HighYield Bonds VREX Q1 2026 Earnings EPS Barely Misses Estimates as Stock Edges Lower AgEagle Aerial Systems UAVS Q3 2023 Earnings Narrowing Losses Amid Strategic Pivot ClearSign Technologies CLIR Q1 2026 Earnings WiderThanExpected Loss Stalls Recovery Hopes Banc of California Inc BANC Q1 2026 Earnings EPS Surpasses Estimates Amid Solid Operating Performance Hamilton Insurance Group Ltd HG Q1 2026 Earnings EPS Beat Drives Positive Note Despite Marginal Share Decline SLGN Q1 2026 Earnings EPS Beats Estimates by 246 Driven by Operational Efficiency TransCode Therapeutics RNAZ Surges 2 as Biotech Stock Tests Key Resistance at 655 Megan Holdings MGN Slips 365 as 016 Tests Support Zone Bullfrog AI Holdings BFRG Edges Higher as Shares Test Resistance Near 070 Cingulate Inc CING Drops Over 16 in Heavy Trading Testing Key Support Nuveen NASDAQ 100 Dynamic Overwrite Fund QQQX Edges Higher as Covered Call Strategy Gains Traction Chancellor Reeves Mobilizes Support to Retain Post Amid Potential Labour Leadership Change WVE Q1 2026 Earnings EPS Beat with 607 Surprise Shares Dip Anfield Energy Shares Gain Ground as Uranium Sector Shows Strength BTC Development Corp BDCI Holds Steady Near Support as Volume Remains Tepid Grande Group Limited GRAN Gains 396 as Price Tests Key Resistance at 110 Alliance Resource Partners ARLP Holds Steady Amid Mixed Market Signals Wendys WEN Nears Support as Stock Slips 047 Key Levels in Focus Tarsus Pharmaceuticals TARS Shows Resilience Near Support After Moderate Decline Better Home Finance Holding Warrants BETRW Slide Sharply as Support Level Under Threat Intellia Therapeutics NTLA Edges Higher Testing Resistance Near 1323